The recent poor performance of stocks, caused in part by the uncertainty over the Greek debt crisis and volatility in China's markets, means that many investors may be tempted to steer clear of them. But one equity fund that offers a "brighter spot" is the MFM Slater Growth Fund, writes Leonora Walters in the Investors Chronicle.
Run by Mark Slater, the son of investment guru Jim Slater, the fund's performance speaks for itself. Over five years, it has been the third best-performer in the Investment Association UK All Companies sector and is among the top performers over one and three years, beating the FTSE All-Share and the FTSE 250. Overall, it has returned 20.1% over one year, 83.9% over three years and 151% over five years.
The fund's remit is to achieve capital growth by investing in stocks with "superior growth potential". Slater holds a portfolio of 25 to 50 UK stocks, but can also buy overseas shares (he currently holds Walt Disney). He uses the price/earnings to growth (PEG) ratio to value shares, while looking for strong brands, sustainable earnings, strong cash flow and director buying.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Around 70% of holdings are in smaller stocks, with 17% in support service firms and 15% in media companies. According to trustnet.com, Slater sees his biggest holding Hutchison China Meditech as the "leading drug development business in [China] bar none", which offers exposure to Chinese healthcare but via the safety of a UK-quoted firm. Investors in a fund such as this need to be comfortable with volatile small stocks, but for those who are, it could be an interesting option. The ongoing charge is 1.56%.
Contact: 020-7220 9460
MFM Slater Growth Fund's top ten holdings
| Hutchison China Meditech | 7.58% |
| Walt Disney Holdings | 4.35% |
| Bellway | 3.61% |
| Regus | 3.53% |
| Redcentric | 3.24% |
| First Derivatives | 3.12% |
| Restore | 3.07% |
| Marston's | 3.06% |
| ITV | 2.50% |
| Essentra | 2.42% |
-
Somero: trading this overlooked bargainFeatures Mechanical-screed maker Somero dominates its niche and is attractively valued. Matthew Partridge picks the best way to trade it.
-
How to find big profits in small companiesCover Story The small- and micro-cap sectors are risky and volatile. But with careful research and patience, investors could make huge gains. Matthew Partridge explains how to find the market’s top tiddlers.
-
The hidden gems on Aim, London's junior marketFeatures Aim, London’s junior market, is risky – but you can find solid stocks at low prices. Scott Longley reports.
-
Is Aim finally coming of age?Features The Aim market of mostly smaller companies has traditionally been seen as a bit of a backwater. Is it time to change that view? Matthew Partridge talks to Paul Latham and Richard Power of fund management company Octopus.
-
Fetch! The Chinese small-cap stocks to buy in the Year of the DogOpinion Each week, a professional investor tells us where she’d put her money. This week: Tiffany Hsiao of Matthews Asia selects three Chinese small-cap stocks with exciting potential.
-
Small and mid-cap stocks with big potential
Opinion Professional investor Guy Anderson of the Mercantile Investment Trust selects three small and medium-sized firms with promising prospects that the market has missed.
-
Get cheap, reliable growth from smaller companiesFeatures One of the most reliable long-term investment trends is the long-term outperformance of smaller companies over blue chips. Max King picks some of the best ways to buy into this growth.
-
Big gains from small caps
Features In an environment of middling inflation and low interest rates, small-cap stocks tend to beat big blue-chips. John Stepek explains why, and how to invest in them.
